73 related articles for article (PubMed ID: 20539003)
41. Collateral expression of proangiogenic and tumorigenic properties in intestinal epithelial cell variants selected for resistance to anoikis.
Rak J; Mitsuhashi Y; Sheehan C; Krestow JK; Florenes VA; Filmus J; Kerbel RS
Neoplasia; 1999 Apr; 1(1):23-30. PubMed ID: 10935467
[TBL] [Abstract][Full Text] [Related]
42. Biological role of the HGF/MET ligand/receptor couple in bovine mammary epithelial cells.
Accornero P; Luvarà S; Favole A; Macchi E; Motta M; Baratta M
Vet Res Commun; 2007 Aug; 31 Suppl 1():161-4. PubMed ID: 17682865
[No Abstract] [Full Text] [Related]
43. Oncogenic Met receptor induces ectopic structures in Xenopus embryos.
Ishimura A; Lee HS; Bong YS; Saucier C; Mood K; Park EK; Daar IO
Oncogene; 2006 Jul; 25(31):4286-99. PubMed ID: 16518409
[TBL] [Abstract][Full Text] [Related]
44. Elucidation of the mechanism underlying CD44v6-induced transformation of IEC-6 normal intestinal epithelial cells.
Chung SY; Huang WC; Chen ZS; Chao TC; Su Y
J Cell Physiol; 2020 Jan; 235(1):194-209. PubMed ID: 31219187
[TBL] [Abstract][Full Text] [Related]
45. Different point mutations in the met oncogene elicit distinct biological properties.
Giordano S; Maffe A; Williams TA; Artigiani S; Gual P; Bardelli A; Basilico C; Michieli P; Comoglio PM
FASEB J; 2000 Feb; 14(2):399-406. PubMed ID: 10657996
[TBL] [Abstract][Full Text] [Related]
46. Systematic Interrogation of Cellular Signaling in Live Cells Using a Membrane-Anchored DNA Multitasking Processor.
Chen S; Xu Z; Li S; Liang H; Zhang C; Wang Z; Li J; Li J; Yang H
Angew Chem Int Ed Engl; 2022 Mar; 61(11):e202113795. PubMed ID: 34990055
[TBL] [Abstract][Full Text] [Related]
47. Andrographolide enhanced 5-fluorouracil-induced antitumor effect in colorectal cancer via inhibition of c-MET pathway.
Su M; Qin B; Liu F; Chen Y; Zhang R
Drug Des Devel Ther; 2017; 11():3333-3341. PubMed ID: 29200829
[TBL] [Abstract][Full Text] [Related]
48. Attenuation of MET-mediated migration and invasion in hepatocellular carcinoma cells by SOCS1.
Gui Y; Khan MGM; Bobbala D; Dubois C; Ramanathan S; Saucier C; Ilangumaran S
World J Gastroenterol; 2017 Sep; 23(36):6639-6649. PubMed ID: 29085209
[TBL] [Abstract][Full Text] [Related]
49. Caspase-mediated proteolysis of the sorting nexin 2 disrupts retromer assembly and potentiates Met/hepatocyte growth factor receptor signaling.
Duclos CM; Champagne A; Carrier JC; Saucier C; Lavoie CL; Denault JB
Cell Death Discov; 2017; 3():16100. PubMed ID: 28179995
[TBL] [Abstract][Full Text] [Related]
50. Non-canonical dynamic mechanisms of interaction between the p66Shc protein and Met receptor.
Landry M; Pomerleau V; Saucier C
Biochem J; 2016 Jun; 473(11):1617-27. PubMed ID: 27048591
[TBL] [Abstract][Full Text] [Related]
51. Tumour-promoting role of SOCS1 in colorectal cancer cells.
Tobelaim WS; Beaurivage C; Champagne A; Pomerleau V; Simoneau A; Chababi W; Yeganeh M; Thibault P; Klinck R; Carrier JC; Ferbeyre G; Ilangumaran S; Saucier C
Sci Rep; 2015 Sep; 5():14301. PubMed ID: 26391193
[TBL] [Abstract][Full Text] [Related]
52. Use of signal specific receptor tyrosine kinase oncoproteins reveals that pathways downstream from Grb2 or Shc are sufficient for cell transformation and metastasis.
Saucier C; Papavasiliou V; Palazzo A; Naujokas MA; Kremer R; Park M
Oncogene; 2002 Mar; 21(12):1800-11. PubMed ID: 11896612
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
Qian F; Engst S; Yamaguchi K; Yu P; Won KA; Mock L; Lou T; Tan J; Li C; Tam D; Lougheed J; Yakes FM; Bentzien F; Xu W; Zaks T; Wooster R; Greshock J; Joly AH
Cancer Res; 2009 Oct; 69(20):8009-16. PubMed ID: 19808973
[TBL] [Abstract][Full Text] [Related]
54. Hepatocyte growth factor and Met in tumor biology and therapeutic approach with NK4.
Matsumoto K; Nakamura T; Sakai K; Nakamura T
Proteomics; 2008 Aug; 8(16):3360-70. PubMed ID: 18646008
[TBL] [Abstract][Full Text] [Related]
55. Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells.
Comoglio PM
EXS; 1993; 65():131-65. PubMed ID: 8380735
[TBL] [Abstract][Full Text] [Related]
56. Oncogenic engagement of the Met receptor is sufficient to evoke angiogenic, tumorigenic, and metastatic activities in rat intestinal epithelial cells.
Bernier J; Chababi W; Pomerleau V; Saucier C
Am J Physiol Gastrointest Liver Physiol; 2010 Sep; 299(3):G677-86. PubMed ID: 20539003
[TBL] [Abstract][Full Text] [Related]
57. Met receptor-induced Grb2 or Shc signals both promote transformation of intestinal epithelial cells, albeit they are required for distinct oncogenic functions.
Pomerleau V; Landry M; Bernier J; Vachon PH; Saucier C
BMC Cancer; 2014 Apr; 14():240. PubMed ID: 24708867
[TBL] [Abstract][Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
